BUY Emcure Pharmaceuticals — Vaishali Parekh, 08 Jul 2026

BUYEmcure Pharmaceuticals Limited

⏳ Pending entry — level not yet reached

byVaishali Parekh, Prabhudas LilladherHorizon: NA (inferred 1–3 months)8 Jul 2026via NDTV Profit (Live)

Entry₹1,700Stated

Target₹2,200

Total upside +29.41%

Stop lossNot given

CMP₹1,926.81h ago

ActiveNA 4 wk left

Follow Vaishali Parekh for new calls(48% target hit, 21 closed calls)Get alerts Watch EMCURE for new buy/sell callsGet alerts See 10 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 5:45 pm IST

14 supporting4 neutral2 opposing

Supports the BUY call (14)

Emcure Pharma: Here's Why ICICI Direct Calls It A High-Conviction 'Buy'

NewsNdtv-Profit·7 Sept · today

Broker’s call: Emcure Pharma (Buy)

NewsHbl·4 Sept · 3d ago

4 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·4 Sept · 3d ago

Neutral / worth noting (4)

Market Trading Guide: Emcure Pharma among 2 stock recommendations for Monday

NewsEt-Markets·6 Sept · yesterday

Coal India, Emcure Pharma, Finolex Cables, GIC, Gulf Oil Lubricants Dividends: Last Day To Buy Shares To Qualify

NewsNdtv-Profit·3 Sept · 4d ago

EMCURE PHARMACEUTICALS L Share Price

NewsGoogle News·25 Aug · 2w ago

Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·7 Sept · today

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Emcure Pharmaceuticals Limited — Vaishali Parekh, Prabhudas Lilladher

AI Assessment